Comparison of Bracing With Co-aptation Splinting for the Initial Treatment of Acute Humeral Shaft Fractures: The COBRAS Trials
Launched by NYU LANGONE HEALTH · Nov 1, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The COBRAS Trial is a study designed to find out which method of treating recent arm fractures, specifically fractures in the upper arm bone (humerus), is more comfortable for patients in the emergency room. The two methods being compared are a special brace called Sarmiento bracing and a type of splint known as coaptation splinting. Researchers will look at how much pain patients feel, how many pain medications they use, and how well they can use their arm over a two-week period.
To participate in this trial, individuals must be at least 18 years old and have a fresh humeral shaft fracture that is not severe enough to require surgery. Participants should not have complex injuries or other serious medical issues. Those who take part can expect to receive one of the two treatments and will be monitored for their comfort and recovery during the study period. This trial aims to improve the way arm fractures are treated, making the recovery process easier for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Presenting to an emergency room or ICARE in the participating centers with an acute humeral shaft fracture
- • 2. Age above 18 and skeletally mature
- • 3. Isolated Injury
- • 4. Treated non-operatively first 2 weeks
- Exclusion Criteria:
- • 1. Open fractures
- • 2. Poly trauma
- • 3. Injuries deemed operative by attending surgeon
- • 4. Patients undergoing treatment for malignancy
- • 5. Prisoners
About Nyu Langone Health
NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Garden City, New York, United States
Queens, New York, United States
Patients applied
Trial Officials
Abhishek Ganta, MD
Principal Investigator
NYU Langone Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials